> top > docs > PubMed:10764835 > spans > 801-1035 > annotations

PubMed:10764835 / 801-1035 JSONTXT

Annnotations TAB JSON ListView MergeView

Inflammaging

Id Subject Object Predicate Lexical cue
T6 0-234 Sentence denotes These findings suggest that heparanase elaboration and control of catalytic activity may contribute to the development and pathogenesis of vascular disease and suggest that heparanase intervention might be a useful therapeutic target.
T6 0-234 Sentence denotes These findings suggest that heparanase elaboration and control of catalytic activity may contribute to the development and pathogenesis of vascular disease and suggest that heparanase intervention might be a useful therapeutic target.

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T6 0-234 Sentence denotes These findings suggest that heparanase elaboration and control of catalytic activity may contribute to the development and pathogenesis of vascular disease and suggest that heparanase intervention might be a useful therapeutic target.
T6 0-234 Sentence denotes These findings suggest that heparanase elaboration and control of catalytic activity may contribute to the development and pathogenesis of vascular disease and suggest that heparanase intervention might be a useful therapeutic target.

uniprot-human

Id Subject Object Predicate Lexical cue
T4 28-38 http://www.uniprot.org/uniprot/Q9Y251 denotes heparanase

uniprot-mouse

Id Subject Object Predicate Lexical cue
T4 28-38 http://www.uniprot.org/uniprot/Q6YGZ1 denotes heparanase
T5 173-183 http://www.uniprot.org/uniprot/Q6YGZ1 denotes heparanase

GlycoBiology-NCBITAXON

Id Subject Object Predicate Lexical cue
T5 6-14 http://purl.bioontology.org/ontology/STY/T033 denotes findings

GO-BP

Id Subject Object Predicate Lexical cue
T6 107-118 http://purl.obolibrary.org/obo/GO_0032502 denotes development
T9 66-84 http://purl.obolibrary.org/obo/GO_0003824 denotes catalytic activity
T10 123-135 http://purl.obolibrary.org/obo/GO_0009405 denotes pathogenesis

EDAM-topics

Id Subject Object Predicate Lexical cue
T11 139-155 http://edamontology.org/topic_3335 denotes vascular disease
T12 148-155 http://edamontology.org/topic_0634 denotes disease
T13 227-233 http://edamontology.org/topic_0154 denotes target

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
10764835-5#28#38#gene10855 28-38 gene10855 denotes heparanase
10764835-5#173#183#gene10855 173-183 gene10855 denotes heparanase
10764835-5#139#155#diseaseC0042373 139-155 diseaseC0042373 denotes vascular disease
28#38#gene10855139#155#diseaseC0042373 10764835-5#28#38#gene10855 10764835-5#139#155#diseaseC0042373 associated_with heparanase,vascular disease
173#183#gene10855139#155#diseaseC0042373 10764835-5#173#183#gene10855 10764835-5#139#155#diseaseC0042373 associated_with heparanase,vascular disease

pubmed-enju-pas

Id Subject Object Predicate Lexical cue
EnjuParser_T116 0-5 DT denotes These
EnjuParser_T117 6-14 NNS denotes findings
EnjuParser_T118 15-22 VBP denotes suggest
EnjuParser_T119 23-27 IN denotes that
EnjuParser_T120 28-38 NN denotes heparanase
EnjuParser_T121 39-50 NN denotes elaboration
EnjuParser_T122 51-54 CC denotes and
EnjuParser_T123 55-62 NN denotes control
EnjuParser_T124 63-65 IN denotes of
EnjuParser_T125 66-75 JJ denotes catalytic
EnjuParser_T126 76-84 NN denotes activity
EnjuParser_T127 85-88 MD denotes may
EnjuParser_T128 89-99 VB denotes contribute
EnjuParser_T129 100-102 TO denotes to
EnjuParser_T130 103-106 DT denotes the
EnjuParser_T131 107-118 NN denotes development
EnjuParser_T132 119-122 CC denotes and
EnjuParser_T133 123-135 NN denotes pathogenesis
EnjuParser_T134 136-138 IN denotes of
EnjuParser_T135 139-147 JJ denotes vascular
EnjuParser_T136 148-155 NN denotes disease
EnjuParser_T137 156-159 CC denotes and
EnjuParser_T138 160-167 VBP denotes suggest
EnjuParser_T139 168-172 IN denotes that
EnjuParser_T140 173-183 NN denotes heparanase
EnjuParser_T141 184-196 NN denotes intervention
EnjuParser_T142 197-202 MD denotes might
EnjuParser_T143 203-205 VB denotes be
EnjuParser_T144 206-207 DT denotes a
EnjuParser_T145 208-214 JJ denotes useful
EnjuParser_T146 215-226 JJ denotes therapeutic
EnjuParser_T147 227-233 NN denotes target
EnjuParser_R118 EnjuParser_T117 EnjuParser_T116 arg1Of findings,These
EnjuParser_R119 EnjuParser_T117 EnjuParser_T118 arg1Of findings,suggest
EnjuParser_R120 EnjuParser_T137 EnjuParser_T118 arg2Of and,suggest
EnjuParser_R121 EnjuParser_T137 EnjuParser_T119 arg1Of and,that
EnjuParser_R122 EnjuParser_T121 EnjuParser_T120 arg1Of elaboration,heparanase
EnjuParser_R123 EnjuParser_T121 EnjuParser_T122 arg1Of elaboration,and
EnjuParser_R124 EnjuParser_T123 EnjuParser_T122 arg2Of control,and
EnjuParser_R125 EnjuParser_T123 EnjuParser_T124 arg1Of control,of
EnjuParser_R126 EnjuParser_T126 EnjuParser_T124 arg2Of activity,of
EnjuParser_R127 EnjuParser_T126 EnjuParser_T125 arg1Of activity,catalytic
EnjuParser_R128 EnjuParser_T122 EnjuParser_T127 arg1Of and,may
EnjuParser_R129 EnjuParser_T128 EnjuParser_T127 arg2Of contribute,may
EnjuParser_R130 EnjuParser_T122 EnjuParser_T128 arg1Of and,contribute
EnjuParser_R131 EnjuParser_T128 EnjuParser_T129 arg1Of contribute,to
EnjuParser_R132 EnjuParser_T132 EnjuParser_T129 arg2Of and,to
EnjuParser_R133 EnjuParser_T132 EnjuParser_T130 arg1Of and,the
EnjuParser_R134 EnjuParser_T131 EnjuParser_T132 arg1Of development,and
EnjuParser_R135 EnjuParser_T133 EnjuParser_T132 arg2Of pathogenesis,and
EnjuParser_R136 EnjuParser_T132 EnjuParser_T134 arg1Of and,of
EnjuParser_R137 EnjuParser_T136 EnjuParser_T134 arg2Of disease,of
EnjuParser_R138 EnjuParser_T136 EnjuParser_T135 arg1Of disease,vascular
EnjuParser_R139 EnjuParser_T128 EnjuParser_T137 arg1Of contribute,and
EnjuParser_R140 EnjuParser_T138 EnjuParser_T137 arg2Of suggest,and
EnjuParser_R141 EnjuParser_T122 EnjuParser_T138 arg1Of and,suggest
EnjuParser_R142 EnjuParser_T143 EnjuParser_T138 arg2Of be,suggest
EnjuParser_R143 EnjuParser_T143 EnjuParser_T139 arg1Of be,that
EnjuParser_R144 EnjuParser_T141 EnjuParser_T140 arg1Of intervention,heparanase
EnjuParser_R145 EnjuParser_T141 EnjuParser_T142 arg1Of intervention,might
EnjuParser_R146 EnjuParser_T143 EnjuParser_T142 arg2Of be,might
EnjuParser_R147 EnjuParser_T141 EnjuParser_T143 arg1Of intervention,be
EnjuParser_R148 EnjuParser_T147 EnjuParser_T143 arg2Of target,be
EnjuParser_R149 EnjuParser_T147 EnjuParser_T144 arg1Of target,a
EnjuParser_R150 EnjuParser_T146 EnjuParser_T145 arg1Of therapeutic,useful
EnjuParser_R151 EnjuParser_T147 EnjuParser_T146 arg1Of target,therapeutic

GlyCosmos600-GlycoProteins

Id Subject Object Predicate Lexical cue
PD-GlycoProteins-B_T6 28-38 https://acgg.asia/db/gpdb/id/GPDB0002205 denotes heparanase
PD-GlycoProteins-B_T7 173-183 https://acgg.asia/db/gpdb/id/GPDB0002205 denotes heparanase
PD-GlycoProteins-B_T13 28-38 https://acgg.asia/db/gpdb/id/GPDB0005896 denotes heparanase
PD-GlycoProteins-B_T14 173-183 https://acgg.asia/db/gpdb/id/GPDB0005896 denotes heparanase

mondo_disease

Id Subject Object Predicate Lexical cue mondo_id
T2 139-155 Disease denotes vascular disease http://purl.obolibrary.org/obo/MONDO_0005385